Cargando…

A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema

BACKGROUND: Autoimmune polyglandular syndrome type 2 represents an uncommon endocrine disorder composed by Addison's disease with autoimmune thyroid disease (Schmidt's syndrome) and/or type 1 diabetes mellitus. Scleromyxedema is a rare progressive cutaneous mucinosis usually associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Prylutskyi, Oleksander, Prylutska, Olga, Degonskyi, Anatoliy, Tkachenko, Kseniia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research and Publications Office of Jimma University 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389067/
https://www.ncbi.nlm.nih.gov/pubmed/28446858
_version_ 1782521223445479424
author Prylutskyi, Oleksander
Prylutska, Olga
Degonskyi, Anatoliy
Tkachenko, Kseniia
author_facet Prylutskyi, Oleksander
Prylutska, Olga
Degonskyi, Anatoliy
Tkachenko, Kseniia
author_sort Prylutskyi, Oleksander
collection PubMed
description BACKGROUND: Autoimmune polyglandular syndrome type 2 represents an uncommon endocrine disorder composed by Addison's disease with autoimmune thyroid disease (Schmidt's syndrome) and/or type 1 diabetes mellitus. Scleromyxedema is a rare progressive cutaneous mucinosis usually associated with systemic involvement and paraproteinemia. To the best of our knowledge, there is no case report of Schmidt's syndrome associated with scleromyxedema. CASE DETAILS: A 34-year-old woman was admitted to Donetsk Clinical Territorial Medical Association due to acute general weakness, reduced vision, dryness of integuments, memory decline, fatigue, weight loss, rash on the face trunk and extremities. A diagnosis of APS type II was made comprising of autoimmune hypothyroidism and autoimmune adrenal insufficiency. Skin histopathologic examination demonstrated the presence of mucin deposits, dermal fibrosis, fibrocytes and perivascular inflammation. In the absence of monoclonal paraproteinemia and the presence of typical histological and clinical signs, an atypical form of scleromyxedema was diagnosed. The patient was administered a lifetime replacement levothyroxine and methylprednisolone therapy. CONCLUSION: Identification and adequate treatment of both APS type II and scleromyxedema in affected patients pose a problem due to the lack of facilities for diagnosis and management plus common misdiagnosis. Early diagnosis should be made before the development of life-threatening complications.
format Online
Article
Text
id pubmed-5389067
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Research and Publications Office of Jimma University
record_format MEDLINE/PubMed
spelling pubmed-53890672017-04-26 A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema Prylutskyi, Oleksander Prylutska, Olga Degonskyi, Anatoliy Tkachenko, Kseniia Ethiop J Health Sci Case Report BACKGROUND: Autoimmune polyglandular syndrome type 2 represents an uncommon endocrine disorder composed by Addison's disease with autoimmune thyroid disease (Schmidt's syndrome) and/or type 1 diabetes mellitus. Scleromyxedema is a rare progressive cutaneous mucinosis usually associated with systemic involvement and paraproteinemia. To the best of our knowledge, there is no case report of Schmidt's syndrome associated with scleromyxedema. CASE DETAILS: A 34-year-old woman was admitted to Donetsk Clinical Territorial Medical Association due to acute general weakness, reduced vision, dryness of integuments, memory decline, fatigue, weight loss, rash on the face trunk and extremities. A diagnosis of APS type II was made comprising of autoimmune hypothyroidism and autoimmune adrenal insufficiency. Skin histopathologic examination demonstrated the presence of mucin deposits, dermal fibrosis, fibrocytes and perivascular inflammation. In the absence of monoclonal paraproteinemia and the presence of typical histological and clinical signs, an atypical form of scleromyxedema was diagnosed. The patient was administered a lifetime replacement levothyroxine and methylprednisolone therapy. CONCLUSION: Identification and adequate treatment of both APS type II and scleromyxedema in affected patients pose a problem due to the lack of facilities for diagnosis and management plus common misdiagnosis. Early diagnosis should be made before the development of life-threatening complications. Research and Publications Office of Jimma University 2016-09 /pmc/articles/PMC5389067/ /pubmed/28446858 Text en Copyright © Jimma University, Research & Publications Office 2016
spellingShingle Case Report
Prylutskyi, Oleksander
Prylutska, Olga
Degonskyi, Anatoliy
Tkachenko, Kseniia
A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema
title A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema
title_full A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema
title_fullStr A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema
title_full_unstemmed A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema
title_short A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema
title_sort case of autoimmune polyglandular syndrome .ype 2 associated with atypical form of scleromyxedema
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389067/
https://www.ncbi.nlm.nih.gov/pubmed/28446858
work_keys_str_mv AT prylutskyioleksander acaseofautoimmunepolyglandularsyndromeype2associatedwithatypicalformofscleromyxedema
AT prylutskaolga acaseofautoimmunepolyglandularsyndromeype2associatedwithatypicalformofscleromyxedema
AT degonskyianatoliy acaseofautoimmunepolyglandularsyndromeype2associatedwithatypicalformofscleromyxedema
AT tkachenkokseniia acaseofautoimmunepolyglandularsyndromeype2associatedwithatypicalformofscleromyxedema
AT prylutskyioleksander caseofautoimmunepolyglandularsyndromeype2associatedwithatypicalformofscleromyxedema
AT prylutskaolga caseofautoimmunepolyglandularsyndromeype2associatedwithatypicalformofscleromyxedema
AT degonskyianatoliy caseofautoimmunepolyglandularsyndromeype2associatedwithatypicalformofscleromyxedema
AT tkachenkokseniia caseofautoimmunepolyglandularsyndromeype2associatedwithatypicalformofscleromyxedema